基本信息
views: 41
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Bispo is a microbiologist dedicated to developing better ways to diagnose, treat, and prevent infections. With training in innovation in clinical and molecular microbiology, his work is at the translational interface between laboratory research and clinical practice. His research focuses on the use of state-of-the-art molecular genetic and genomic approaches to develop new, rapid, sensitive, and comprehensive diagnostic tests. He is also using a combination of genomic and phenotypic approaches to study the epidemiology of antibiotic-resistant infections, biofilm-formation on artificial devices, and the development of novel approaches for prophylaxis and treatment of ocular and otolaryngology infections. He serves as an assistant director for the Harvard Ophthalmology Infectious Diseases Institute (IDI), and manager of the IDI’s Translational Research Initiative.
Research Interests
Papers共 91 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Gabriela Marinho Righetto,Norival Alves Santos-Filho, Leticia Oliveira Catarin Nunes,Camille Andre, Julia Medeiros Souza,Adriano Defini Andricopulo,Paulo Jose Martins Bispo,Eduardo Maffud Cilli,Ilana Lopes Baratella da Cunha Camargo
ACS OMEGAno. 22 (2024): 23662-23674
OCULAR IMMUNOLOGY AND INFLAMMATIONpp.1-5, (2023)
Science Translational Medicineno. 690 (2023)
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023): 1265471-1265471
Proteoglycan researchno. 3 (2023)
American journal of ophthalmology (2023): 43-56
Journal of Medical Mycologyno. 2 (2023): 101384-101384
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn